TITLE

New computerized tool allows precise detection, correction of color blindness

AUTHOR(S)
Cimberle, Michela
PUB. DATE
March 2011
SOURCE
Ocular Surgery News;3/25/2011, Vol. 29 Issue 6, p16
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article offers information on an automated device used for the precise detection and correction of color blindness.
ACCESSION #
86439077

 

Related Articles

  • pseudoisochromatic.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1923 

    A definition of the medical term "pseudoisochromatic," which refers to colors used in charts designed for color blindness assessment, is presented.

  • Moody's Memoranda. Moody, John // Insight: Non-Destructive Testing & Condition Monitoring;May2014 Supplement, p6 

    The article offers information on the farnsworth panel D-15, an online colour vision test and also highlights the use of digital imaging in radiography and ultrasonic testing for detection of colour vision deficiency and also mentions the symptoms and causes of colour blindness.

  • INTERACTIVE METHOD OF DETECTING COLOR VISION DISORDERS IN CANDIDATES FOR DRIVERS. BOBER, DARIUSZ; LASKOWSKI, MACIEJ; KĘSIK, JACEK // Studia i Materialy Polskiego Stowarzyszenia Zarzadzania Wiedza /;2011, Issue 42, p5 

    The problems with detecting color vision disorders in candidates for drivers are discussed in this paper. Authors analyze the methods currently used to detect various types of color vision disorders in driving schools and their effectiveness. This problem is especially important in many...

  • Prevalence of Red-Green Color Vision Defects among Muslim Males and Females of Manipur, India. Shah, Ahsana; Hussain, Ruqaiya; Fareed, Mohd; Afzal, Mohammad // Iranian Journal of Public Health;Jan2013, Vol. 42 Issue 1, p16 

    Background: Color blindness is a common X-linked genetic disorder. However, most of color blinds remain unde-tected due to absence of proper screening. Our study was to determine the prevalence of red-green color vision de-fects among Manipuri Muslim males and females. The study could help in...

  • Comparison between Hardy-Rand-Rittler 4th edition and Ishihara color plate tests for detection of dyschromatopsia in optic neuropathy. Huna-Baron, Ruth; Glovinsky, Yoseph; Habot-Wilner, Zohar // Graefe's Archive of Clinical & Experimental Ophthalmology;Feb2013, Vol. 251 Issue 2, p585 

    Background: The aim of this work was to compare the specificity-sensitivity balance of the Hardy-Rand-Rittler (HRR) 4th edition with the Ishihara color plate tests for color-vision defects in patients with optic neuropathy. Methods: This is a prospective case-control study. The study group...

  • Color Me Curious. Karpecki, Paul M.; Shechtman, Diana L. // Review of Optometry;2/15/2013, Vol. 150 Issue 2, p100 

    The article discusses color vision deficiencies (CVDs) that are diagnosed by color vision testing which is also useful in the diagnosis glaucoma and retinal disease. It mentions that CVDs are caused by X-linked mutations and the basic difference between congenital and acquired CVDs is the...

  • LAB BABBLE. Swan, Russ // Laboratory News;May2015, p14 

    The article focuses on the crowd-funding device project of the University of East Anglia (UEA) which help enhance the video for the colour-blind people in Great Britain. It highlights the development of a neurological implant which stimulate the colour receptors on the retina or the image...

  • Customized tailor-made optic technology promising for astigmatic correction. Cimberle, Michela // Ocular Surgery News;3/25/2011, Vol. 29 Issue 6, p17 

    The article focuses on the study by doctor Pierre-Jean Pisella on the new toric intraocular lens (IOL) which offers optimal quality of vision and customized astigmatic correction.

  • Endosense secures a total of $44.6M in Series C funding.  // Medical Device Daily;3/ 6/2013, Vol. 17 Issue 44, p2 

    The article focuses on the aim of contact-force sensing technology developer, Endosense, to improve the safety of catheter ablation for the treatment of cardiac arrhythmias (CA) by securing $4.3 million in Series C financing from a new strategic industry partner. According to Endosense...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics